Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy

Journal of Urology

Volumn 191, Issue 2, 2014, Pages 316-322

  Rink, Michael ^a   Sharifi, Nasim ^a   Fritsche, Hans Martin ^b   Aziz, Atiqullah ^b   Miller, Florian ^c   Kluth, Luis A ^a   Ngamsri, Theofanis ^c   Dahlem, Roland ^a   Chun, Felix K ^a   Shariat, Shahrokh F ^d   Stenzl, Arnulf ^c   Fisch, Margit ^a   Gakis, Georgios ^c  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

anemia; carcinoma; hemoglobins; kidney; ureter

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CANCER MORTALITY; CANCER PATIENT; FEMALE; FOLLOW UP; HEMOGLOBIN DETERMINATION; HUMAN; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEPHROURETERECTOMY; OUTCOME ASSESSMENT; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TRANSITIONAL CELL CARCINOMA; TUMOR NECROSIS; AGE DISTRIBUTION; CANCER RECURRENCE; CANCER SURGERY; MEDICAL DECISION MAKING; ONCOLOGY; PATIENT COUNSELING; RACE DIFFERENCE; SEX DIFFERENCE; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

ANEMIA; BLADDER UROTHELIAL CARCINOMA; CARCINOMA; COMPUTERIZED TOMOGRAPHY; CT; HEMOGLOBINS; KIDNEY; LVI; LYMPHOVASCULAR INVASION; RADICAL NEPHROURETERECTOMY; RNU; UCB; UPPER TRACT UROTHELIAL CARCINOMA; URETER; URETERORENOSCOPY; URS; UTUC;

AGED; ANEMIA; BLOOD LOSS, SURGICAL; COMORBIDITY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREOPERATIVE PERIOD; RECURRENCE; RETROSPECTIVE STUDIES; URETER; UROLOGIC NEOPLASMS; UROLOGIC SURGICAL PROCEDURES; UROTHELIUM;

EID: 84891961347     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.09.010     Document Type: Article

References (30)

1. V. Margulis, S.F. Shariat, and S.F. Matin et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration Cancer 115 2009 1224
2. M. Rink, D. Sjoberg, and E. Comploj et al. Risk of cancer-specific mortality following recurrence after radical nephroureterectomy Ann Surg Oncol 19 2012 4337
3. M. Roupret, R. Zigeuner, and J. Palou et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update Eur Urol 59 2011 584
4. J.D. Raman, J. Messer, and J.A. Sielatycki et al. Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005 BJU Int 107 2011 1059
5. M. Rink, E.K. Cha, and D. Green et al. Biomolecular predictors of urothelial cancer behavior and treatment outcomes Curr Urol Rep 13 2012 122
6. S.J. Van Belle, and V. Cocquyt Impact of haemoglobin levels on the outcome of cancers treated with chemotherapy Crit Rev Oncol Hematol 47 2003 1
7. H.M. Bruins, T. Arends, and M. Pelkman et al. The prognostic value of pre-operative parameters in patients undergoing radical cystectomy for bladder cancer J Urol 189 2013 e584
8. N. Tanaka, E. Kikuchi, and S. Shirotake et al. The predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional study Eur Urol 2012 Epub ahead of print
9. T.F. Chromecki, E.K. Cha, and H. Fajkovic et al. The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy Eur Urol 61 2012 245
10. M. Rink, B.D. Robinson, and D.A. Green et al. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma J Urol 188 2012 398
11. M. Roscigno, S.F. Shariat, and V. Margulis et al. The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed? Eur Urol 56 2009 512
12. M. Rink, B. Ehdaie, and E.K. Cha et al. Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery Eur Urol 62 2012 677
13. S.B. Edge, D.R. Byrd, and C.C. Compton et al. American Joint Committee on Cancer (AJCC) Staging Manual 7th ed. 2010 Springer New York
14. J.I. Epstein, M.B. Amin, and V.R. Reuter et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee Am J Surg Pathol 22 1998 1435
15. M. Remzi, A. Haitel, and V. Margulis et al. Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients BJU Int 103 2009 307
16. R. Zigeuner, S.F. Shariat, and V. Margulis et al. Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract Eur Urol 57 2010 575
17. E. Kikuchi, V. Margulis, and P. Karakiewicz et al. Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma J Clin Oncol 27 2009 612
18. M. Rink, H. Fajkovic, and E.K. Cha et al. Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma Eur Urol 61 2012 854
19. Nutritional anaemias. Report of a WHO scientific group World Health Organ Tech Rep Ser 405 1968 5
20. E. Beutler, and J. Waalen The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood 107 2006 1747
21. F.E. Harrell Jr., R.M. Califf, and D.B. Pryor et al. Evaluating the yield of medical tests JAMA 247 1982 2543
22. F.E. Harrell Jr., K.L. Lee, and D.B. Mark Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 1996 361
23. E.W. Steyerberg, F.E. Harrell Jr., and G.J. Borsboom et al. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis J Clin Epidemiol 54 2001 774
24. K. Bensalah, F. Montorsi, and S.F. Shariat Challenges of cancer biomarker profiling Eur Urol 52 2007 1601
25. Birgegard G, Aapro MS, Bokemeyer C, et al. Cancer-related anemia: pathogenesis, prevalence and treatment. Oncology, suppl., 2005; 68: 3.
26. G. Fechner, F. Dederichs, and D. Schmidt et al. Hyperoxia-induced improvement of the in vitro response to gemcitabine in transitional cell carcinoma Anticancer Res 25 2005 3413
27. Sabbatini P: The relationship between anemia and quality of life in cancer patients. Oncologist, suppl., 2000; 5: 19.
28. S. Mercadante, V. Gebbia, and A. Marrazzo et al. Anaemia in cancer: pathophysiology and treatment Cancer Treat Rev 26 2000 303
29. E. Xylinas, M. Rink, and V. Margulis et al. Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy BJU Int 112 2013 453
30. B.J. Linder, I. Frank, and J.C. Cheville et al. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy Eur Urol 63 2013 839